Eligible Medications

Eligible Medications

ViiVConnect offers savings and assistance programs for patients who are insured, underinsured, and uninsured. Learn more below about ViiV Healthcare medications that are eligible for savings and assistance.

ViiVConnect offers savings and assistance programs for patients who are insured, underinsured, and uninsured. Learn more below about ViiV Healthcare medications that are eligible for savings and assistance.

 

APRETUDE

(cabotegravir)

vc card

APRETUDE

Savings Program*

Extended-release injectable suspensions: cabotegravir 200 mg/mL
 

Up to $7850 per year

Patient Assistance Program (PAP)*

Extended-release injectable suspensions: cabotegravir 200 mg/mL

APRETUDE

(cabotegravir)

vc card

APRETUDE

Savings Program*

Extended-release injectable suspensions: cabotegravir 200 mg/mL

Up to $7500 per year

Patient Assistance Program (PAP)*

Extended-release injectable suspensions: cabotegravir 200 mg/mL

CABENUVA

(cabotegravir; rilpivirine)

vc card

CABENUVA

Savings Program*

Extended-release injectable suspensions: cabotegravir 200 mg/mL; rilpivirine 300 mg/mL

Up to $13,000 per year

Patient Assistance Program (PAP)*

Extended-release injectable suspensions: cabotegravir 200 mg/mL; rilpivirine 300 mg/mL

DOVATO

(dolutegravir and lamivudine)

id-card

ViiVConnect Savings Card*

Tablets: 50 mg dolutegravir and 300 mg lamivudine

Up to $6250 per year with no monthly limit

eVoucherRx icon

eVoucherRx™*

Tablets: 50 mg dolutegravir and and 300 mg lamivudine

Up to $6250 per year with no monthly limit

Patient Assistance
Program (PAP)*

Tablets: 50 mg dolutegravir and 300 mg lamivudine

EPIVIR

(lamivudine)

Patient Assistance Program (PAP)*

Tablets: 150 mg

Oral Solution: 10 mg/mL

JULUCA

(dolutegravir and rilpivirine)

ViiVConnect
Savings Card*

Tablets: 50 mg dolutegravir and 25 mg rilpivirine

Up to $6250 per year with no monthly limit

eVoucherRx icon

eVoucherRx™*

Tablets: 50 mg dolutegravir and and 25 mg rilpivirine

Up to $6250 per year with no monthly limit

Patient Assistance Program (PAP)*

Tablets: 50 mg dolutegravir and 25 mg rilpivirine

RETROVIR

(zidovudine)

ViiVConnect
Savings Card*

Injection, for Intravenous use:
10 mg/mL (20 mL vial)


Up to $4800 per year with no monthly limit

Patient Assistance Program (PAP)*

Capsules: 100 mg
Oral Solution: 10 mg/mL

RUKOBIA

(fostemsavir)

ViiVConnect
Savings Card*

Extended-Release Tablets: 600 mg

Up to $7500 per year with no monthly limit

Patient Assistance Program (PAP)*

Extended-Release Tablets: 600 mg

SELZENTRY

(maraviroc)

ViiVConnect
Savings Card*

Tablets: 25 mg

Tablets: 300 mg

Tablets: 75 mg

Oral Solution:

Tablets: 150 mg

20 mg/mL

Up to $4800 per year with no monthly limit

Patient Assistance Program (PAP)*

Tablets: 150 mg
Tablets: 300 mg

TIVICAY

(dolutegravir)

ViiVConnect
Savings Card*

Tablets: 10 mg
Tablets: 25 mg
Tablets: 50 mg


Up to $5000 per year with no monthly limit

eVoucherRx icon

eVoucherRx™*

Tablets: 10 mg
Tablets: 25 mg
Tablets: 50 mg

Up to $5000 per year with no monthly limit

Patient Assistance Program (PAP)*

Tablets: 50 mg

TIVICAY PD

(dolutegravir)

ViiVConnect
Savings Card*

Tablets for Oral Suspension: 5 mg

Up to $5000 per year with no monthly limit

eVoucherRx icon

eVoucherRx™*

Tablets for Oral Suspension: 5 mg

Up to $5000 per year with no monthly limit

Patient Assistance Program (PAP)*

Tablets for Oral Suspension: 5 mg

TRIUMEQ

(abacavir, dolutegravir, and lamivudine)

ViiVConnect
Savings Card*

Tablets: 600 mg abacavir, 50 mg dolutegravir, and 300 mg lamivudine

Up to $7500 per year with no monthly limit

eVoucherRx icon

eVoucherRx™*

Tablets: 600 mg abacavir, 50 mg dolutegravir and 300 mg lamivudine

Up to $7500 per year with no monthly limit

Patient Assistance Program (PAP)*

Tablets: 600 mg abacavir, 50 mg dolutegravir, and 300 mg lamivudine

TRIUMEQ PD

(abacavir, dolutegravir, and lamivudine)

ViiVConnect
Savings Card*

Tablets for Oral Suspension: 60 mg abacavir, 5 mg dolutegravir, and 30 mg lamivudine

Up to $7500 per year with no monthly limit

eVoucherRx icon

eVoucherRx™*

Tablets for Oral Suspension: 60 mg abacavir, 5 mg dolutegravir, and 30 mg lamivudine,

Up to $7500 per year with no monthly limit

TRIZIVIR

(abacavir, lamivudine, and zidovudine)

ViiVConnect
Savings Card*

Tablets: 300 mg abacavir, 150 mg lamivudine, and 300 mg zidovudine

Up to $4800 per year with no monthly limit

VIRACEPT

(nelfinavir mesylate)

ViiVConnect
Savings Card*

Tablets: 250 mg nelfinavir free base
Tablets: 625 mg nelfinavir free base


Up to $4800 per year with no monthly limit

Patient Assistance Program (PAP)*

Tablets: 250 mg nelfinavir free base
Tablets: 625 mg nelfinavir free base

ZIAGEN

(abacavir)

ViiVConnect
Savings Card*

Oral Solution: 20 mg/mL

Up to $4800 per year with no monthly limit

Patient Assistance Program (PAP)*

Oral Solution: 20 mg/mL

Subject to eligibility, program terms, and conditions. ViiVConnect programs do not constitute health insurance.

 

Total savings not to exceed $7500 per year. Restrictions apply. Offer limited to 1 per person.

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

CBTWCNT220065